Core J: MOUSE MODELS

$428,858U54FY2014HLNIH

University Of Pennsylvania, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 38854091 Paper 37703883 Paper 35817977 Paper 34725480 Paper 34390827 Paper 33883067 Paper 33689683 Paper 33462483 Paper 33290746 Paper 32587965 Paper 32286125 Paper 32093736 Paper 31553718 Paper 31051039 Paper 31015404 Paper 30992314 Paper 30929268 Paper 30923381 Paper 30833575 Paper 30737317 Paper 30710016 Paper 30645204 Paper 30606731 Paper 30586711 Paper 30571171 Paper 30455703 Paper 30305427 Paper 30108257 Paper 30062222 Paper 30044978 Paper 30017553 Paper 30013180 Paper 29930022 Paper 29695417 Paper 29687419 Paper 29676940 Paper 29599139 Paper 29449357 Paper 29353239 Paper 29301865 Paper 29026445 Paper 29025710 Paper 28975675 Paper 28887514 Paper 28811382 Paper 28797240 Paper 28710775 Paper 28651847 Paper 28615003 Paper 28595709 Paper 28396408 Paper 28280170 Paper 28238887 Paper 28160743 Paper 28102731 Paper 28089180 Paper 27997993 Paper 27941783 Paper 27840335 Paper 27813829 Paper 27788309 Paper 27756840 Paper 27713681 Paper 27547824 Paper 27476658 Paper 27448436 Paper 27435673 Paper 27142391 Paper 27133131 Paper 27129261 Paper 27059979 Paper 26980701 Paper 26959112 Paper 26776202 Paper 26771163 Paper 26703471 Paper 26701907 Paper 26697163 Paper 26472898 Paper 26338770 Paper 26240359 Paper 26136511 Paper 26121262 Paper 26049587 Paper 25915600 Paper 25907923 Paper 25845931 Paper 25831442 Paper 25814526 Paper 25691688 Paper 25623160 Paper 25559454 Paper 25548276 Paper 25533351 Paper 25502615 Paper 25428363 Paper 25422430 Paper 25417097 Paper 25396741 Trial NCT02502006

Abstract

The mouse is the most commonly used animal in biomedical research comprising >90% of all animal experimentation. This mammalian species is often the prime choice to flesh out mechanisms of action of drugs and to establish biochemical signaling pathways prior to entering human trials. Directly relevant to PENTACON, mice were used to predict and then assign mechanistic understanding to all recognized features ¿ thrombosis, hypertension, heart failure, dysrhythmia ¿ of the cardiovascular hazard in humans taking COX-2 selective NSAIDs (1,2). More than 20 genetic mouse models that disrupt or perturb the COX biosyntheticresponse pathway have been developed by PENTACON members, a unique resource for use in this proposal.

View original record on NIH RePORTER →